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Phosphoribosylamine (PRA) is the
first intermediate in the common pathway
to purines and thiamine, and is generated
i n b a c t e r i a b y g l u t a m i n e
phosphoribosylpyrophosphate (PRPP)
amidotransferase (PurF, EC 2.4.2.14) from
PRPP and glutamine. Genetic data have
indicated that multiple, non-PurF
mechanisms exist to generate PRA
sufficient for thiamine, but not purine
synthesis. Here we describe the purification
and identification of an activity (present in
both E. coli and S. enterica) that synthesizes
PRA from ribose-5-phosphate (R5P) and
glutamine/asparagine. A purification
resulting in greater than a 625-fold increase
in specific activity identified eight candidate
proteins. Of the candidates, overexpression
of AphA (EC 3.1.3.2), a periplasmic class B
non-specific acid phosphatase, significantly
increased activity in partially purified
extracts. Native purification of AphA to
>95% homogeneity determined that the
periplasmic L-asparaginase II, AnsB (EC
3.5.1.1), co-purified with AphA and was
also necessary for PRA formation. The
potential physiological relevance of AphA
and AnsB in contributing to thiamine
biosynthesis in vivo is discussed.
INTRODUCTION
In bacteria, phosphoribosylamine
(PRA) is the first intermediate in the
biosynthetic pathways for purines and the
pyrimidine moiety of thiamine (1-4) (Figure
1). Glutamine-PRPP amidotransferase (E.C.
2.4.2.14), the product of the purF gene in
Salmonella enterica (and Escherichia coli),
catalyzes the synthesis of PRA from PRPP
and glutamine. Strains lacking PurF have the
expected nutritional requirement for purines,
however under some growth conditions S.
enterica strains lacking PurF are able to grow
in the absence of thiamine (5,6). Genetic and
biochemical studies have demonstrated this
growth reflects the existence of a PurF-
independent mechanism(s) to generate PRA
that is utilized by subsequent purine and
thiamine enzymes to generate the
hydroxymethyl pyrimidine (HMP) moiety of
thiamine (7,8). However, PRA generated in
the absence of PurF is not sufficient to satisfy
the cellular requirement for purines.
An inability to obtain mutants devoid
of PRA formation suggests multiple activities
that can generate this metabolite. PRA could
be generated by side reaction(s) of enzyme(s)
involved in other metabolic pathways,
redistribution of metabolic flux, or a
combination of the two. Results implicating
t h e a n t h r a n i l a t e synthase-
phosphoribosyltransferase complex (TrpDE,
EC 4.1.3.27, EC 2.4.2.18), required in
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2tryptophan biosynthesis, in synthesis of PRA
(9,10) are consistent with this scenario.
Genetic studies have shown that a functional
oxidative pentose phosphate (OPP) pathway is
required for at least one route of PRA
biosynthesis independent of PurF and distinct
from the Trp enzymes (6,9,11). Nutritional
studies were consistent with a role of the OPP
pathway in contributing ribose-5-phosphate
(R5P) for PRA synthesis (Figure 1) (6,11,12).
The study described here was initiated
to test the hypothesis that a PRA-forming
activity utilizing R5P as a substrate is present
in bacterial cells. Here we describe the
identification and purification of a PRA-
forming activity present in E. coli and S .
enterica which converts R5P and asparagine
or glutamine to PRA. Purification of this
activity from crude extract determined it
required two proteins encoded by aphA and
ansB.
EXPERIMENTAL PROCEDURES
Medium and chemicals. Culture media
supplies were obtained from Difco (Sparks,
MD). Glutamine, asparagine, glycine, ribose-
5-phosphate, PRPP, magnesium acetate,
ammonium chloride, ATP, EDTA, -
mercaptoethanol, phenylmethanesulfonyl
fluoride (PMSF), protamine sulfate, DNase I
(EC 3.1.21.1), and lysozyme (EC 3.2.1.17)
were obtained from Sigma-Aldrich (St, Louis,
MO). KCl, sucrose, MgCl2, Tris base,
methanol, and pyridine were from Fisher
Scientific (Pittsburgh, PA). K2HPO4, KH2PO4,
and ammonium sulfate were obtained from
Mallinckrodt Baker (Phillipsburg, NJ). [1-
14
C]-glycine was from New England Nuclear
(Boston, MA). DEAE Sepharose Fast Flow
and all chromatography resin were obtained
from Amersham Pharmacia Biotech
(Piscataway, NJ). Cellulose PEI plates were
from Selecto Scientific (Suwanee, GA).
Ultrafiltration YM membranes were from
Amicon (Beverly, MA). All restriction
enzymes used were from Promega (Madison,
WI). AnsB (EC 3.5.1.1) from E. coli (catalog
number A4887) was obtained from Sigma-
Aldrich (St, Louis, MO).
Strains, cell growth, extract preparation.
Strain DM1293 (E. coli, purF::Tn10) was
grown in Luria-Bertani (LB) broth in a 16 L
batch fermentor. Strain DM1936 (S. enterica,
purF2085) was grown in Nutrient Broth (NB)
in a 16 L batch fermentor. The medium was
inoculated with one liter of an overnight
culture and incubated at 37
o
C with aeration
during 12 h. Cells (~88 g) were harvested by
centrifugation at 4
o
C, washed twice with
buffer A (0.05 M potassium phosphate buffer
pH 7.5 containing 5 mM -mercaptoethanol
and 1 mM PMSF), and resuspended in 200
mL of the same buffer. The cells were
disrupted using a French pressure cell at 10
4
kPa. Clarified cell-free extract was obtained
by centrifugation at 23,700 X g during 45 min
at 4
o
C. When grown on a smaller scale, media
was inoculated with a NB overnight culture
and incubated at 37
o
C with agitation until full
cell density was achieved. Cell-free extracts
were then generated as described above.
Assay for PRA-formation. A PRA-forming
activity assay described for glutamine-PRPP
amidotransferase (4,13) was modified to
optimize sensitivity. PRA synthesis was
assayed in 50 mM potassium phosphate buffer
pH 8.0 in the presence of 6 mM magnesium
acetate, 2.5 mM ATP, 2 mM
14
C-glycine (26
nCi), a pool of amino acids containing equal
concentrations (6 mM) of glutamine,
asparagine, and 2 μg of GAR synthetase.
Reactions were started by the addition of R5P
(13 mM final concentration), and incubated at
37
o
C for 4 h. Radio-labeled GAR and glycine
were separated by thin-layer chromatography
(TLC) on PEI-cellulose using a
methanol:pyridine:water system (20:1:5). The
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3position of radioactive spots was detected
using a Cyclone Storage Phosphor System
(Packard Instrument Company), and their
identity was confirmed with standards.
Protein purification. Glycinamide
ribonucleotide (GAR) synthetase (PurD).
GAR synthetase was purified to 95%
homogeneity from E. coli strain, DM1295
(purF ::Tn10d/pJS187). Plasmid pJS187
provides for the over-expression of GAR
synthetase (14). PurD protein was purified as
described using ammonium sulfate
fractionation, ion exchange chromatography
(DEAE resin), and size exclusion
chromatography (14). The activity of the
purified protein was assayed by monitoring
14
C-GAR production from
14
C-glycine and
chemically synthesized PRA (4,13,15).
Alternatively, PurD was purified by affinity
chromatography using the IMPACT CN Kit
(New England Biolabs, Ipswich, MA). A C-
terminal intein tag was created by amplifying
the open reading frame of purD from S .
enterica LT2 chromosomal DNA by PCR
using Platinum Pfx DNA polymerase
(Invitrogen, Carlsbad, CA). This construct
was cloned into the NdeI and SmaI site of the
plasmid pTYB2. Over-expression and
purification of the protein were performed as
recommended by the manufacturer and
resulted in a native protein containing a single
additional glycine at the N-terminal end.
Preparations of PurD purified by either
method were used interchangeably with no
affect on ability to detect PRA forming
activity.
PRA-forming activity. Nucleic acids were
precipitated by addition of protamine sulfate
to the clarified cell-free extract at a final
concentration of 0.1% with constant stirring
over 10 min. The solution was then stirred for
30 additional min and centrifuged at 23,700 X
g during 20 min. A two-step salt precipitation
was performed. The clarified cell-free extract
was brought to 35% saturation by the addition
of solid ammonium sulfate with constant
stirring during 30 min. The solution was then
stirred for 30 additional min and centrifuged at
23,700 X g for 30 min. The same procedure
was used in a second precipitation step
performed at 70% saturation. The supernatant
at 70% saturation was discarded and the
precipitate was resuspended in buffer A (0.05
M potassium phosphate buffer pH 7.5
containing 5 mM -mercaptoethanol and 1
mM PMSF) and dialyzed against the same
buffer. The dialyzed fraction was applied at a
flow rate of 2 mL/min to a DEAE ion
exchange column (200 mL column volume)
equilibrated with buffer A. The column was
washed with two column volumes (CV) of
buffer A and all PRA-forming activity was
found to be in the flow-through and wash
fractions. These fractions were pooled and
concentrated using a 30 kDa cut-off Amicon
ultrafiltration membrane. The concentrated
fraction was applied at a flow rate of 0.5
mL/min to a HiLoad Superdex 75 size
exclusion column (24 m CV) equilibrated with
buffer A containing 100 mM KCl; 1-mL
fractions were collected and assayed for PRA-
forming activity. The active fractions were
applied at a flow rate of 2 mL/min to a
MonoQ (strong ion exchange) column (8 mL
CV) equilibrated with buffer A. After a two
CV wash with buffer A, a linear gradient from
0 to 1 M KCl was used to elute the proteins
bound to the column; 1mL fractions were
collected throughout the wash and elution.
After dialyzing against buffer A, the fractions
were tested for PRA-forming activity and
stored at 4
o
C.
An alternative step was used
interchangeably with the DEAE column
chromatographic step. In this alternative, 100
cubic centimeters of unpacked DEAE resin
equilibrated with buffer A was mixed with the
dialyzed fractions and the suspension was
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4placed on ice for 10 min. Trial experiments
determined that this batch elution protocol
resulted in purification of the PRA-forming
activity with the same efficiency as collecting
the flow-through from standard column
chromatography. The supernatant was
removed by filtration. The resin was washed
with an additional 200 mL of buffer A, which
was then pooled with the 200 mL supernatant
and concentrated using a using a 30 kDa cut-
off Amicon ultrafiltration membrane and
applied to a Superdex 75 size exclusion
column (see above).
A p h A . Strain DM10089 (p u r F 2 0 8 5
ansB1::Kan pSU-aphA) was grown in NB
with chloramphenicol (20 g/mL) in a 16 L
batch fermentor and the cells were collected
by centrifugation. Proteins from the
periplasmic space were isolated using a
modified spheroplasting technique (16). The
resulting protein preparation was subjected to
the purification scheme described for the
PRA-forming activity. SDS-PAGE protein
bands were visualized by staining with a
Silver Stain Plus kit from Bio-Rad (Hercules,
CA) and the protein prep was determined to
be >95% pure after passage through a
Superdex 75 size exclusion column (data not
shown). The protein prep was then stored at
4°C for two months or frozen and stored at -
80°C for future use.
Protein quantification and manipulation.
Protein was quantified by the method of
Bradford (17) or by using a BCA Protein
Assay Kit (Pierce). Ultrapure bovine serum
albumin was used to generate a standard
curve. After SDS-polyacrylamide gel
electrophoresis (SDS-PAGE) protein bands
were visualized by staining with either (a)
4 0 : 5 5 : 5 : 0 . 0 5 e t h a n o l : w a t e r : a c e t i c
acid:Coomassie G-250 and distained in
40:55:5 ethanol:water:acetic acid; or (b) silver
using a Silver Stain Plus kit from Bio-Rad
(Hercules, CA).
Analysis of candidate genes. Candidate
genes were amplified from S. enterica LT2
chromosomal DNA by PCR using Platinum
Pfx DNA polymerase (Invitrogen, Carlsbad,
CA) with the primers shown in Table I. The
resulting PCR products were purified and
cloned into the multi cloning site of pSU19
(18). Plasmids were electroporated into E. coli
strain DH5 and screened for vectors
containing inserts. Constructs containing the
cloned genes under the control of the lac
promoter were confirmed by sequence
analysis and introduced into S. enterica strain
DM1936
Candidate proteins were partially
purified from cell-free extracts of strains over-
expressing them. Cells (~3 g) were
resuspended in buffer A (6 mL) with 2mg/mL
lysozyme and 1mg/mL DNase prior to
disruption with a French pressure cell at 10
4
kPa. Clarified cell-free extract was obtained
by centrifugation at 39,000 X g during 30 min
at 4
o
C. The clarified cell-free extract was at
65°C for 5 min, centrifuged at 39,000 X g for
45 min at 4°C, and run by gravity feed over
two DEAE columns (6 mL CV) equilibrated
with buffer A running in tandem at 4
o
C. A 6
mL wash was combined with the flow-through
fraction and concentrated with a 30 kDa cut-
off Amicon ultrafiltration membrane.
RESULTS
Optimization of in vitro assay for PRA
formation. Past protocols for PRA-formation
have utilized a coupled reaction with
glycinamide ribotide synthetase (PurD) in
which the substrate (
14
C-glycine) is separated
from the product (
14
C-GAR) by ion exchange
chromatography, based on the charge
conferred by the phosphate group in GAR (4).
Use of this assay in crude cell-free extracts
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5was hampered by non-specific phosphatases
that partially converted GAR to GARs and
thus decreased the sensitivity of the assay.
Because the activity of interest was expected
to be weak, a TLC system using a mobile
phase of methanol/pyridine/water (20:1:5) on
PEI- cellulose plates was used to separate
unincorporated
14
C-glycine from the
14
C-
GAR/
14
C-GARs.
Initial screens for PRA-forming
activity were preformed in S. enterica and E.
coli cell-free extracts lacking glutamine-PRPP
amidotransferase. Either PRPP or R5P was
provided as the carbon backbone donor and a
pool of amino acids containing glutamine,
asparagine, alanine, and valine (each at 6 mM)
as the potential source of the amino group.
Subsequent experiments determined that
glutamine and asparagine were equally
proficient as amino donors, and no other
amino acid allowed PRA formation. Control
experiments determined PRA was formed in
the absence of extract (data not shown) if R5P
was provided to the Tris-HCl buffer used in
previous work (pH 8.0, 100 mM) (4). Since
PRA can be chemically synthesized from R5P
and ammonia this non-enzymatic formation
was attributed to small amounts of ammonia
in the buffer (15,19). Additional buffers
(HEPES-NaOH, Clark and Lubs KH2PO4-
NaOH; pH. 8, 50 mM) were discarded for a
similar reason, or because the (PurD) activity
was negatively affected. Potassium phosphate
buffer (pH 8.0) was found to produce
negligible background PRA formation and
was used in subsequent experiments.
Initial characterization of a PRA-forming
activity in cell-free extracts lacking PurF.
Dialyzed cell-free extracts from S. enterica
and E. coli. strains lacking glutamine-PRPP
amidotransferase failed to support synthesis of
PRA from either R5P or PRPP, glutamine and
asparagine. It was subsequently found that
synthesis of PRA from R5P, glutamine and
asparagine was detectable after the cell-free
extract had interacted with an anion exchange
resin (DEAE, pH 7.5) and/or subjected to
65°C for 5 min. Detection of this activity is
shown in Figure 2. Data in Figure 2A show
that in the presence of fractionated extract,
formation of GAR was detectable when R5P
(lane 2), but not PRPP (data not shown) was
provided with amino acids. The PRA-forming
activity was decreased when heated at 98
o
C
for 5 min (lane 3), and retained after dialysis
(lane 4). Further, the activity was unaffected
by treatment with either RNase or DNase
(data not shown). Accumulation of GAR was
proportional to the time of assay incubation up
to 4 hr, as shown by data from a representative
experiment in Figure 2B. Data in Figure 2C
show that GAR synthesis was proportional to
protein up to 15 μg, after which a plateau was
reached. The data in Figures 2B and 2C are
from a representative experiment and GAR
concentration was determined from a linear
curve of radio-labeled glycine generated under
visualization conditions.
Inability to detect PRA-forming
activity in crude cell-free extracts prior to
fractionation suggested the presence of an
inhibitory compound. Subsequent experiments
determined the target of inhibition was the
PurD reaction, and it was not further
characterized.
Purification of PRA-forming activity. PRA-
forming activity was followed during
fractionation of an E. coli strain lacking
glutamine-PRPP amidotransferase (DM1293
(E. coli purF77::Tn10d)). A purification
protocol was implemented and is summarized
in Table II. A typical purification used 250
mL of cell-free extract (8 mg/mL) fractionated
by precipitation with ammonium sulfate as
described in Experimental Procedures. The
proteins precipitated at 70% saturation were
resuspended in buffer A and dialyzed against
the same buffer . Ion exchange
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6chromatography was performed on the
dialyzed fractions (200 mL). PRA-forming
activity was detectable at this stage in the
flow-through fraction and this activity was set
to be 100% for subsequent yield
determination.
After interaction with the DEAE resin,
the PRA-forming activity was further purified
and concentrated by passage through a 30 kDa
cut-off Amicon ultrafiltration membrane,
followed by size exclusion chromatography
and ion exchange chromatography as
described in Experimental Procedures. Data in
Table II indicates a 625-fold final purification
was achieved.
Proteins in the active fractions from
the purification were visualized after
separation on SDS-polyacrylamide gel. The
fraction from the Mono Q column contained
multiple protein bands (data not shown). Final
active fractions from three independent
purifications, and an inactive fraction from the
final column were sent to Midwest Bio
Services (Overland Park, KS) for in-gel
extraction and mass spectrometry analysis.
Table III summarizes the proteins identified in
all active fractions, and not present in the
inactive fraction.
Partially purified AphA has PRA forming
activity. Genes encoding each of the eight
proteins described in Table III were amplified
from S. enterica and cloned into a pSU19
multi-copy plasmid. The resulting constructs
were introduced into the S. enterica strain
DM1936 (purF2085). Cell free extracts from
the resulting strains were subjected to partial
purification and assayed for PRA-forming
activity. Of the eight strains, two had more
PRA synthesis than the parental strain (Figure
3). The strain over-expressing AphA (lane 1),
and the strain over-expressing AnsB (lane 2)
were found to have increased PRA formation
relative to the control strain DM1936 (lane 4).
Purified AnsB was purchased (Sigma Chem.
Co.) and tested for its ability to make PRA.
While AnsB allowed PRA formation (lane3)
two points were noted. First, 10μg of AnsB
allowed less PRA formation than crude extract
of the AphA overproducing strain. Second, as
an asparaginase, AnsB produces NH3 and thus
PRA formation is expected to be at least
partially due to the non-enzymatic
combination of ammonia and R5P (15).
AphA and AnsB are required for PRA
forming activity. AphA was purified from
strain DM9518 (purF2085 pSU-aphA) to
>95% homogenicity and tested for PRA-
forming activity. Ten micrograms of this
protein preparation generated more PRA than
the partially purified extract from DM9518
(data not shown), although there was a
noticeable contaminating protein band of
approximately the size of the AnsB protein
(~35KD). To address the possible contribution
of AnsB to the detected PRA-forming activity,
a strain lacking AnsB and PurF activities was
generated. Plasmid pSU-aphA was moved into
this strain to create DM10089 (purF2085
ansB1::Kan pSU-aphA ). AphA was then
purified after over-expression in the ansB
mutant background, and found to have no
PRA-forming activity. Additional protein
preparations confirmed that AphA is not
sufficient to catalyze PRA formation.
Data in Figure 4 showed that while
neither 10g of AphA (lane 1) or AnsB (lane
2) allowed significant PRA formation, a
mixture of the two proteins did. In the
presence of less than molar amounts of AnsB,
AphA was able to generate significant
amounts of PRA. From these data it was
concluded that the PRA-forming activity
purified from crude extracts was due to a
complex involving the periplasmic proteins
AphA and AnsB.
Physiological role of AphA and AnsB in
thiamine biosynthesis. Results described here
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7showed that AphA and AnsB have the ability
to produce PRA in vitro. Strain DM10259
(purF2085 ansB1::Kan aphA15::Cm) was
constructed and analyzed for growth under
various conditions known to allow PurF-
independent PRA formation. In all growth
conditions tested, the strain lacking ansB and
aphA grew as well as the parental p u r F
mutant, indicating this PRA-forming activity
was not essential for growth. When aphA or
ansB was placed in multi-copy, neither
allowed a purF mutant strain to grow in the
absence of thiamine under non-permissive
conditions (data not shown).
DISCUSSION
This study describes the identification
and purification of a cellular activity from
both E. coli and S. enterica that synthesizes
phosphoribosyl amine (PRA). Data herein
showed that AphA, a periplasmic class B non-
specific acid phosphatase/phosphotransferase
(EC 3.1.3.2), in combination with submolar
ratios of the periplasmic L-asparaginase II,
AnsB (EC 3.5.1.1), can produce PRA from
R5P and either asparagine or glutamine in
vitro. Titration experiments determined that
(at pH 7.5) optimal PRA-formation occurred
when AphA and AnsB were provided at a
13:1 molar ratio. We suggest that AphA binds
R5P and catalyzes the formation of PRA when
presented with the ammonia released by
hydrolysis of asparagine or glutamine by
AnsB.
Based on the enzymes involved, a
scenario in which either one could produce
PRA is feasible. Although AphA has been
characterized primarily for its ability to
dephosphorylate mononucleotides and various
other phosphomonoesters, the enzyme has
been shown to catalyze dephosphorylation of
R5P. This finding indicates that the enzyme
can bind R5P, though it is acted on with a
relatively low catalytic efficiency (Kcat/KM of
5.0 x 10
3
M
-1
x s
-1
pH 6) (20). At physiological
pH the protein exhibits sub-optimal activity,
potentially decreasing this catalytic efficiency
further, raising the possibility that R5P could
bind in the active site without
dephosphorylation occurring. In this scenario,
AphA could serve to concentrate R5P,
allowing PRA formation to occur when
ammonia is present. Since AnsB hydrolyzes
both asparagine and glutamine optimally at
pH 7.5 (21), a simple scenario suggests that
AnsB produces ammonia that allows non-
enzymatic formation of PRA in the presence
of R5P (15).
Although more complex scenarios for
the generation of PRA by the individual
enzymes could be imagined, several
observations suggested AphA and AnsB
together were responsible for the PRA
production detected herein. First, AphA and
AnsB co-purified through several
chromatographic steps, consistent with at least
a loose association of the two proteins. The
fact that both enzymes are located in the
periplasm is consistent with this interpretation.
Secondly, the amount of PRA formed with the
addition of both proteins was noticeably more
than that generated by AphA, even with
excess ammonia. We suggest a model in
which PRA is formed in the active site of
AphA. By this scenario R5P would
occasionally bind the AphA enzyme, blocking
the active site due to the poor catalytic activity
of the enzyme with this substrate. This
association would remain until the
glutaminase/asparaginase releases ammonia in
close proximity, perhaps allowing the
interaction of R5P and ammonia resulting in
PRA formation. The inability of PRPP to
allow PRA formation could be due to the
binding specificity of AphA. Alternatively,
the inability of PRPP to participate in the
reaction could support the non-enzymatic
mechanism proposed. If PRA is easily
released from the enzyme, this could benefit
the organism by restoring the availability of
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8the active site for mononucleotide
dephosphorylation. Testing this model will
require additional kinetic analyses in vitro.
While AphA/AnsB could synthesize
PRA in vitro, a condition where these proteins
were essential for thiamine biosynthesis in
vivo was not identified. Localization studies
showed that AphA is present in the cytoplasm
in addition to its predominant location in the
periplasm (22), thus is it rational to suggest
some PRA is generated by the mechanism
described herein. Previous work in our lab has
emphasized the multiple inputs to PRA
formation (9,10,23). In all cases separate from
that described here, these inputs have been
identified using sensitive in vivo genetic
analyses. The work described here emphasizes
that the cell has additional capacity to generate
metabolites that may not be apparent by only
addressing activities essential for growth.
Further, there is not a good way of
determining that the appropriate condition to
detect essentiality has been tested.
The robustness of cellular metabolism
predicts that multiple inputs to many (if not
all) metabolites will exist. Such overlap can be
considered to occur by evolutionary pressure,
or simply be the natural result of biochemical
reactions that involve compounds of similar
structure. Regardless of the evolutionary
questions, from the perspective of
understanding the metabolic network in the
cell it is important to define not only reactions
that are easily recognized as essential for
growth, but the potential for robustness
provided by minor reactions. Based on the
work herein, AphA is component of the cell
that can be probed with in vitro biochemical
approaches to generate a better understanding
of metabolic robustness with respect to PRA
formation.
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Table I
Primers used in this study
Plasmid a Primers used to amplify insert
pIR-mdh
5’-GCCTGTGTCACGCCTCGCAAATAA-3’
5’-GCGACCTGCATGTGCCTGTTGG-3’
pIR-mdoG
5’-CACGTATTCTCAGATTTTTCACCT-3’
5’-CGCGAGTAAGTCCGATGCT-3’
pIR-ydcG
5’-CTGAAGAATGCTGCGTGAGG-3’
5’-GAGCAGCACTTAATAAACCCAGAG-3’
pSU-aphA
5’- GTCGACCCGTTACTGGCGTTATGGTC-3’
5’- GGATCCGTGCAGCAAGTCTGGAAAAG-3’
pSU-cpdB
5’-CTGCAGGGAACGATATCGGGTTTCAC-3’
5’-GGATCCCGGGAACGTTTATCAGATGG-3’
pSU-ansB
5’-CTGCAGTAAACAATGGCGCAGATCG-3’
5’-GGATCCGTGCGAGAGGTCTTCCAAAG-3’
pSU-yghA
5’-GAGAGTCGACGAATACGGGCGAAGCATAAG-3’
5’-CAGAGGATCCAAGTGGCGCCTTGCTTAAC-3’
pSU-talA
5’-GAGACTGCAGGCCTGTCTGCTATGCTTTTTG-3’
5’-GAGAGGATCCCATTGGCAAGGTCTTTACGG-3’
a
 For all plasmids, pSU19 (Cmr) was used
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Table II
Purification of  PRA-forming activity a
Purification Step
Specific activity
Uc/mg protein Purification % Yield
Cell-free extract NDb - -
(NH4)2SO4 precipitation ND - -
DEAE ion exchange
chromatography (flow-through) 506 1 -
Superdex 75 size exclusion
chromatography 10848 22 68%
MonoQ ion exchange
chromatography 316492 625 89%
aPRA synthesis from R5P, glutamine and asparagine was determined a function of
radio-labeled 14C-GAR production
bND: none detected
cU: Arbitrary units detected by the Cyclone Storage Phosphor System
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Fig. 1. Pathway schematics. Biosynthetic pathway for purine and thiamine synthesis.
Some purine gene products are indicated above the reactions they catalyze. The proposed
substrates for the alternative PRA synthesis are R5P and an unknown amino donor.
Abbreviations:  R5P, ribose-5-phosphate; PRPP, phosphoribosylpyrophosphate; PRA,
phosphoribosylamine; GAR, 5’-phosphoribosylglycinamide; AIR, aminoimidazole
ribotide; HMP-PP, 4-amino-5-hydroxymethylpyrimidine pyrophosphate; THZ-P, 4-
methyl-5-(-hydroxyethyl)thiazole-phosphate.
Fig. 2. PRA-forming activity in a partially purified extract from an E. coli purF
mutant. A) Synthesis of PRA as a function of 
14
C-GAR production. Reactions were
performed as described in Experimental Procedures adding an amino acid pool
(glutamine and asparagine) and R5P as substrates, in the absence (lane 1) and the
presence of a fresh (lane 2), boiled (lane 3) or dialyzed (lane 4) partially purified cell
extract. After incubation at 37
o
C during 4 h, radio-labeled 
14
C-GAR and 
14
C-glycine were
separated on PEI-cellulose using a methanol/pyridine/water (20:1:5) solvent system. B)
GAR synthesis vs. time. GAR synthesis from R5P and an amino acid pool in the presence
() and the absence () of the partially purified extract (10 mg total protein). C)
Synthesis of GAR in the presence of increasing amounts of protein after 4 h incubation at
37
o
C.
Fig. 3. PRA forming activity in partially purified protein extracts. PRA formation as
a function of radio-labeled 14C-GAR from R5P, asparagine and glutamine using: 10g of
DM9518 (purF pSU-aphA) (lane 1), 10g of DM9584 (purF pSU-ansB) (lane 2), 10g
pure AnsB from Sigma (lane3), 10g DM1936 (purF) (lane 4), no protein control (lane
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5). After incubation at 37oC during 4 h, radio-labeled 14C-GAR and 14C-glycine were
separated by TLC, and the 14C-GAR spots are shown.
Fig 4. Formation of PRA from AphA and AnsB. PRA formation using purified protein
as a function of radio-labeled 14C-GAR from R5P, asparagine and glutamine using: 10g
AphA (lane 1), 10g AnsB (lane 2), 0.1g AnsB (lane 3), 10g AphA+1.0g AnsB (lane
4), 10g AphA+ 0.1g AnsB (lane 5), 10g AphA+10ng AnsB (lane 6), 10g
AphA+5.0ng AnsB (lane 7), 10g AphA+1.0ng AnsB (lane 8), and no protein control
(lane 9). After incubation at 37oC during 4 h, radio-labeled 14C-GAR and 14C-glycine
were separated by TLC and the 14C-GAR spots are shown.
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